The content on this site is intended for healthcare professionals only
Recent advances in advanced melanoma: ipilimumab (2/6)
Recent advances in advanced melanoma: BRAF inhibitors (3/6)
Combination of newer agents in advanced melanoma (4/6)
Guidelines and recommendations for advanced melanoma (5/6)
Improving pre-clinical experimental models to test anti cancer drugs
Early stage molecular profiling
Emergence of ipilimumab and vemurafenib for melanoma
The P-Medicine project; data sharing and integration for personalised medicine
The changing landscape of melanoma therapies: indications of better patient outcome
Role of vemurafenib in melanoma treatment
Combining oral targeted therapies shows early anti-tumour activity for advanced melanoma
Cancer prevention through education
